Maintenance of the functional integrity of mouse hematopoiesis by EED and promotion of leukemogenesis by EED haploinsufficiency
Kenichiro Ikeda(Hiroshima University), Hiroaki Honda(Tokyo Women's Medical University), Norimasa Yamasaki(Hiroshima University), Toshiya Inaba(Hiroshima University), Tatsuo Ichinohe(Hiroshima University), Keiyo Takubo(Keio University), Takahiko Miyama(The University of Texas MD Anderson Cancer Center), Toshio Suda(Chinese Academy of Sciences), Akinori Kanai(Frontier Medical College), Linda Wolff(National Institutes of Health), Takeshi Ueda(Kindai University), Yasuyuki Sera(Tokyo Women's Medical University), Zen‐ichiro Honda(Ochanomizu University), Yuichiro Nakata(University of Miami), Akio Matsubara(Hiroshima General Hospital), Hiroshi Kobayashi(Jikei University School of Medicine), Hideaki Oda(Hakodate Central General Hospital), Akiko Nagamachi(Hiroshima University)
Cited by 15
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694